DexCom Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Revenue Guidance

04:44 PM EDT, 10/29/2026 (MT Newswires) -- DexCom (DXCM) reported Q3 adjusted earnings late Thursday of $0.73 per diluted share, up from $0.61 a year earlier. Analysts polled by FactSet expected $0.67. Revenue for the quarter ended Sept. 30 was $1.34 billion, up from $1.21 billion a year earlier. Analysts expected $1.32 billion. The company now expects 2026 revenue from $5.20 billion to $5.25 billion, up from its prior range of $5.18 billion to $5.25 billion. Analysts expect $5.23 billion.